These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33532770)

  • 41. Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, against SARS-CoV-2 Challenge in Nonhuman Primates.
    Awasthi M; Macaluso A; Myscofski D; Prigge J; Koide F; Noyce RS; Fogarty S; Stillwell H; Goebel SJ; Daugherty B; Nasar F; Bavari S; Lederman S
    Vaccines (Basel); 2023 Nov; 11(11):. PubMed ID: 38006014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunological evaluation of an inactivated SARS-CoV-2 vaccine in rhesus macaques.
    Chen H; Xie Z; Long R; Fan S; Li H; He Z; Xu K; Liao Y; Wang L; Zhang Y; Li X; Dong X; Mou T; Zhou X; Yang Y; Guo L; Yang J; Zheng H; Xu X; Li J; Liang Y; Li D; Zhao Z; Hong C; Zhao H; Jiang G; Che Y; Yang F; Hu Y; Wang X; Pu J; Ma K; Wang L; Cheng C; Duan W; Shen D; Zhao H; Jiang R; Deng X; Li Y; Zhu H; Zhou J; Yu L; Xu M; Yang H; Yi L; Zhou Z; Yang J; Duan N; Yang H; Zhao W; Yang W; Li C; Liu L; Li Q
    Mol Ther Methods Clin Dev; 2021 Dec; 23():108-118. PubMed ID: 34462721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2.
    Cao H; Mai J; Zhou Z; Li Z; Duan R; Watt J; Chen Z; Bandara RA; Li M; Ahn SK; Poon B; Christie-Holmes N; Gray-Owen SD; Banerjee A; Mossman K; Kozak R; Mubareka S; Rini JM; Hu J; Liu J
    Cell Biosci; 2021 Dec; 11(1):202. PubMed ID: 34879865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The STING Ligand and Delivery System Synergistically Enhance the Immunogenicity of an Intranasal Spike SARS-CoV-2 Vaccine Candidate.
    Jearanaiwitayakul T; Limthongkul J; Kaofai C; Apichirapokey S; Chawengkirttikul R; Sapsutthipas S; Sunintaboon P; Ubol S
    Biomedicines; 2022 May; 10(5):. PubMed ID: 35625879
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets.
    Marsh GA; McAuley AJ; Au GG; Riddell S; Layton D; Singanallur NB; Layton R; Payne J; Durr PA; Bender H; Barr JA; Bingham J; Boyd V; Brown S; Bruce MP; Burkett K; Eastwood T; Edwards S; Gough T; Halpin K; Harper J; Holmes C; Horman WSJ; van Vuren PJ; Lowther S; Maynard K; McAuley KD; Neave MJ; Poole T; Rootes C; Rowe B; Soldani E; Stevens V; Stewart CR; Suen WW; Tachedjian M; Todd S; Trinidad L; Walter D; Watson N; Drew TW; Gilbert SC; Lambe T; Vasan SS
    NPJ Vaccines; 2021 May; 6(1):67. PubMed ID: 33972565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Compartmentalized SARS-CoV-2 Replication in the Upper vs Lower Respiratory Tract After Intranasal Inoculation or Aerosol Exposure.
    Fischer RJ; Bushmaker T; Williamson BN; Pérez-Pérez L; Feldmann F; Lovaglio J; Scott D; Saturday G; Feldmann H; Munster VJ; de Wit E; van Doremalen N
    J Infect Dis; 2024 Sep; 230(3):657-661. PubMed ID: 38261786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters.
    Jia Q; Bielefeldt-Ohmann H; Maison RM; Masleša-Galić S; Cooper SK; Bowen RA; Horwitz MA
    NPJ Vaccines; 2021 Mar; 6(1):47. PubMed ID: 33785745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SARS-CoV-2 Vaccines Elicit Durable Immune Responses in Infant Rhesus Macaques.
    Garrido C; Curtis AD; Dennis M; Pathak SH; Gao H; Montefiori D; Tomai M; Fox CB; Kozlowski PA; Scobey T; Munt JE; Mallroy ML; Saha PT; Hudgens MG; Lindesmith LC; Baric RS; Abiona OM; Graham B; Corbett KS; Edwards D; Carfi A; Fouda G; Van Rompay KKA; De Paris K; Permar SR
    bioRxiv; 2021 Apr; ():. PubMed ID: 33851156
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An alphavirus replicon-based vaccine expressing a stabilized Spike antigen induces protective immunity and prevents transmission of SARS-CoV-2 between cats.
    Langereis MA; Albulescu IC; Stammen-Vogelzangs J; Lambregts M; Stachura K; Miller S; Bosco-Lauth AM; Hartwig AE; Porter SM; Allen M; Mogler M; van Kuppeveld FJM; Bosch BJ; Vermeij P; de Groof A; Bowen RA; Davis R; Xu Z; Tarpey I
    NPJ Vaccines; 2021 Oct; 6(1):122. PubMed ID: 34671047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model.
    Johnston SC; Ricks KM; Lakhal-Naouar I; Jay A; Subra C; Raymond JL; King HAD; Rossi F; Clements TL; Fetterer D; Tostenson S; Cincotta CM; Hack HR; Kuklis C; Soman S; King J; Peachman KK; Kim D; Chen WH; Sankhala RS; Martinez EJ; Hajduczki A; Chang WC; Choe M; Thomas PV; Peterson CE; Anderson A; Swafford I; Currier JR; Paquin-Proulx D; Jagodzinski LL; Matyas GR; Rao M; Gromowski GD; Peel SA; White L; Smith JM; Hooper JW; Michael NL; Modjarrad K; Joyce MG; Nalca A; Bolton DL; Pitt MLM
    Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune Thrombocytopenia Induced by the Chimpanzee Adenovirus-Vectored Vaccine against SARS-CoV-2 Infection.
    Liao PW; Teng CJ; Chou CW
    Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection.
    Jones BE; Brown-Augsburger PL; Corbett KS; Westendorf K; Davies J; Cujec TP; Wiethoff CM; Blackbourne JL; Heinz BA; Foster D; Higgs RE; Balasubramaniam D; Wang L; Bidshahri R; Kraft L; Hwang Y; Žentelis S; Jepson KR; Goya R; Smith MA; Collins DW; Hinshaw SJ; Tycho SA; Pellacani D; Xiang P; Muthuraman K; Sobhanifar S; Piper MH; Triana FJ; Hendle J; Pustilnik A; Adams AC; Berens SJ; Baric RS; Martinez DR; Cross RW; Geisbert TW; Borisevich V; Abiona O; Belli HM; de Vries M; Mohamed A; Dittmann M; Samanovic M; Mulligan MJ; Goldsmith JA; Hsieh CL; Johnson NV; Wrapp D; McLellan JS; Barnhart BC; Graham BS; Mascola JR; Hansen CL; Falconer E
    bioRxiv; 2020 Oct; ():. PubMed ID: 33024963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BNT162b2 Vaccine Encoding the SARS-CoV-2 P2 S Protects Transgenic hACE2 Mice against COVID-19.
    Ji RR; Qu Y; Zhu H; Yang Y; Vogel AB; Sahin U; Qin C; Hui A
    Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33915773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2.
    Zhu L; Deng YQ; Zhang RR; Cui Z; Sun CY; Fan CF; Xing X; Huang W; Chen Q; Zhang NN; Ye Q; Cao TS; Wang N; Wang L; Cao L; Wang H; Kong D; Ma J; Luo C; Zhang Y; Nie J; Sun Y; Lv Z; Shaw N; Li Q; Li XF; Hu J; Xie L; Rao Z; Wang Y; Wang X; Qin CF
    Natl Sci Rev; 2021 Mar; 8(3):nwaa297. PubMed ID: 34676096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Longitudinal multiomic profiling and corticosteroid modulation of the immediate innate immune response to an adenovirus-vector vaccine.
    Jin Choi S; Lee W; Cheol Kim S; Jo HY; Park HY; Bin Kim H; Park WY; Ho Park S; Ko JH; Seok Lee J
    Vaccine; 2024 Nov; 42(25):126118. PubMed ID: 39025696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vectored Immunoprophylaxis and Treatment of SARS-CoV-2 Infection.
    Tada T; Dcosta BM; Minnee J; Landau NR
    bioRxiv; 2023 Jan; ():. PubMed ID: 36711584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway.
    Gagne M; Corbett KS; Flynn BJ; Foulds KE; Wagner DA; Andrew SF; Todd JM; Honeycutt CC; McCormick L; Nurmukhambetova ST; Davis-Gardner ME; Pessaint L; Bock KW; Nagata BM; Minai M; Werner AP; Moliva JI; Tucker C; Lorang CG; Zhao B; McCarthy E; Cook A; Dodson A; Mudvari P; Roberts-Torres J; Laboune F; Wang L; Goode A; Kar S; Boyoglu-Barnum S; Yang ES; Shi W; Ploquin A; Doria-Rose N; Carfi A; Mascola JR; Boritz EA; Edwards DK; Andersen H; Lewis MG; Suthar MS; Graham BS; Roederer M; Moore IN; Nason MC; Sullivan NJ; Douek DC; Seder RA
    bioRxiv; 2021 Oct; ():. PubMed ID: 34729558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An immunoPET probe to SARS-CoV-2 reveals early infection of the male genital tract in rhesus macaques.
    Madden PJ; Thomas Y; Blair RV; Samer S; Doyle M; Midkiff CC; Doyle-Meyers LA; Becker ME; Arif MS; McRaven MD; Simons LM; Carias AM; Martinelli E; Lorenzo-Redondo R; Hultquist JF; Villinger FJ; Veazey RS; Hope TJ
    bioRxiv; 2022 Mar; ():. PubMed ID: 35262081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An immunoPET probe to SARS-CoV-2 reveals early infection of the male genital tract in rhesus macaques.
    Madden PJ; Thomas Y; Blair RV; Samer S; Doyle M; Midkiff CC; Doyle-Meyers LA; Becker ME; Arif MS; McRaven MD; Simons LM; Carias AM; Martinelli E; Lorenzo-Redondo R; Hultquist JF; Villinger FJ; Veazey RS; Hope TJ
    Res Sq; 2022 Apr; ():. PubMed ID: 35411346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mice and non-human primates.
    Zabaleta N; Dai W; Bhatt U; Chichester JA; Sanmiguel J; Estelien R; Michalson KT; Diop C; Maciorowski D; Qi W; Hudspeth E; Cucalon A; Dyer CD; Pampena MB; Knox JJ; LaRocque RC; Charles RC; Li D; Kim M; Sheridan A; Storm N; Johnson RI; Feldman J; Hauser BM; Zinn E; Ryan A; Kobayashi DT; Chauhan R; McGlynn M; Ryan ET; Schmidt AG; Price B; Honko A; Griffiths A; Yaghmour S; Hodge R; Betts MR; Freeman MW; Wilson JM; Vandenberghe LH
    bioRxiv; 2021 Jan; ():. PubMed ID: 33442684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.